JAK4D, a first-in-class thyrotropin-releasing hormone analogue, reverses scopolamine-induced memory deficits

Roisin McMackin, Smita Price, Gillian R Slator, Orla Hardiman, Julie A Kelly

Open source

DOI
10.1093/braincomms/fcag006
Published
2026
Container
Brain Communications
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/braincomms/fcag006,
  title = {JAK4D, a first-in-class thyrotropin-releasing hormone analogue, reverses scopolamine-induced memory deficits},
  author = {Roisin McMackin and Smita Price and Gillian R Slator and Orla Hardiman and Julie A Kelly},
  year = {2026},
  journal = {Brain Communications},
  doi = {10.1093/braincomms/fcag006},
  url = {https://doi.org/10.1093/braincomms/fcag006}
}

RIS

TY  - JOUR
TI  - JAK4D, a first-in-class thyrotropin-releasing hormone analogue, reverses scopolamine-induced memory deficits
AU  - Roisin McMackin
AU  - Smita Price
AU  - Gillian R Slator
AU  - Orla Hardiman
AU  - Julie A Kelly
PY  - 2026
JO  - Brain Communications
DO  - 10.1093/braincomms/fcag006
UR  - https://doi.org/10.1093/braincomms/fcag006
ER  - 

APA

McMackin, R., Price, S., Slator, G. R., Hardiman, O., & Kelly, J. A. (2026). JAK4D, a first-in-class thyrotropin-releasing hormone analogue, reverses scopolamine-induced memory deficits. Brain Communications. https://doi.org/10.1093/braincomms/fcag006

Source records